BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2878556)

  • 1. Expression of dipeptidylaminopeptidase-IV in some human T and B cell lines.
    Srivastava MD; Bhargava AK
    Acta Haematol; 1986; 76(1):25-8. PubMed ID: 2878556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Value of dipeptidylaminopeptidase IV (DAP IV) in various lymphoproliferative syndromes with hemoperipheric expression].
    Marill MR; Woessner S; Lafuente R; Florensa L
    Sangre (Barc); 1986; 31(2):167-73. PubMed ID: 2873661
    [No Abstract]   [Full Text] [Related]  

  • 3. Quantitative and qualitative studies of leukaemic cell dipeptidylpeptidases II and IV.
    Scott CS; Stark AN; Minowada J; Drexler HG
    Leuk Res; 1988; 12(2):129-34. PubMed ID: 2895826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dipeptidylaminopeptidase IV activity in normal and leukemic T-cell subpopulations.
    Crockard AD; MacFarlane E; Andrews C; Bridges JM; Catovsky D
    Am J Clin Pathol; 1984 Sep; 82(3):294-9. PubMed ID: 6380269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subtyping of chronic lymphocytic leukemia of T-type by dipeptidylaminopeptidase IV (DAP IV), monoclonal antibodies, and Fc-receptors.
    Feller AC; Parwaresch MR; Lennert K
    Cancer; 1983 Nov; 52(9):1609-12. PubMed ID: 6137274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dipeptidylaminopeptidase IV (DAP IV) in B- and T-cell leukaemias.
    Andrews C; Crockard AD; San Miguel JF; Catovsky D
    Clin Lab Haematol; 1985; 7(4):359-68. PubMed ID: 2869856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytochemical distribution of dipeptidylaminopeptidase IV (DAP IV; EC-3.4.14.5) in T-lymphoblastic lymphoma/leukemia characterized with monoclonal antibodies.
    Feller AC; Parwaresch MR; Lennert K
    Leuk Res; 1984; 8(3):397-406. PubMed ID: 6379309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative cytochemical study of dipeptidyl aminopeptidase (DAP) II and IV in normal and malignant haemic cells.
    Khalaf MR; Bevan PC; Hayhoe FG
    J Clin Pathol; 1986 Aug; 39(8):891-6. PubMed ID: 2875085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dipeptidylaminopeptidase IV (DAP IV) activity in normal and malignant T-cell subsets as defined by monoclonal antibodies.
    Wirthmüller R; Dennig D; Oertel J; Gerhartz H
    Scand J Haematol; 1983 Sep; 31(3):197-205. PubMed ID: 6192484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytochemistry of dipeptidylaminopeptidase IV and II in normal and neoplastic lymphoid cells.
    Invernizzi R; Bertolino G; Girino M; Perseghin P; Michienzi M; Nano R
    Blut; 1985 May; 50(5):277-85. PubMed ID: 2859898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytochemical reactivity of T mu lymphocytes in human lymphatic tissue for dipeptidylaminopeptidase IV.
    Feller AC
    Histochem J; 1982 Nov; 14(6):889-95. PubMed ID: 6757193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzymecytochemical heterogeneity of human chronic T-lymphocytic leukemia as demonstrated by reactivity to dipeptidylaminopeptidase IV (DAP IV; EC 3.4.14.4).
    Feller AC; Parwaresch MR; Bartels H; Lennert K
    Leuk Res; 1982; 6(6):801-8. PubMed ID: 6759796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dipeptidylpeptidase IV in human leukemic B- and T-cells.
    Bylinkina VS; Lokshina LA; Samojlova RS; Lubkova ON; Gureeva TA; Golubeva NV
    Biochem Int; 1992 Oct; 28(1):31-9. PubMed ID: 1359891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dipeptidylaminopeptidase IV activity in T lymphocyte subsets in B cell non-Hodgkin's lymphomas.
    Cozzi M; Gloghini A; Sulfaro S; Volpe R; Carbone A
    Hum Pathol; 1989 Oct; 20(10):987-93. PubMed ID: 2571558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneous expression of dipeptidyl-amino-peptidase (DAP IV) in T-cell chronic lymphocytic leukemia.
    Chilosi M; Pizzolo G; Semenzato G; de Rossi G; Pandolfi F
    Acta Haematol; 1984; 71(4):277-81. PubMed ID: 6426241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dipeptidyl aminopeptidase-IV in lymphocytes of patients with lymphoproliferative diseases].
    Bylinkina VS; Golubeva NV; Gureeva TA; Lokshina LA; Polianskaia AM; Samoĭlova RS
    Biull Eksp Biol Med; 1989 Jul; 108(7):85-8. PubMed ID: 2572281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistocytochemical correlation of DAP IV-CD 26 reactivity with immunologic markers of lymphocyte activation in human lymphoid tissues.
    Cozzi M; Gloghini A; Volpe R; Carbone A
    Br J Haematol; 1990 Jul; 75(3):325-32. PubMed ID: 1974815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytochemistry of dipeptidylaminopeptidase IV in T lymphoblastic leukaemia-lymphoma.
    Invernizzi R; Perugini O; De Fazio P; Bonetti F; Nespoli BL
    Haematologia (Budap); 1989; 22(3):143-9. PubMed ID: 2573567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Proteolytic enzymes in human lymphocytic leukemia cells. I. Activity of dipeptidylaminopeptidase IV, plasminogen activator and cathepsins B and L in cells with different immunologic phenotype].
    Lokshina LA; Bylinkina VS; Samoĭlova RS; Gureeva TA; Golubeva NV; Polianskaia AM
    Biokhimiia; 1993 Jul; 58(7):1104-15. PubMed ID: 8103371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histochemistry of dipeptidyl aminopeptidase (DAP) II and IV in reactive lymphoid tissues and malignant lymphoma.
    Khalaf MR; Aqel NM; Hayhoe FG
    J Clin Pathol; 1987 May; 40(5):480-5. PubMed ID: 2884235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.